Zimmer Biomet Holdings, Inc. (ZBH)
USD 105.86
(-2.04%)
USD 105.86
(-2.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.02 Billion USD | 342.52% |
| 2022 | 231.4 Million USD | -42.38% |
| 2021 | 401.6 Million USD | 392.29% |
| 2020 | -137.4 Million USD | -112.14% |
| 2019 | 1.13 Billion USD | 398.42% |
| 2018 | -379.2 Million USD | -120.61% |
| 2017 | 1.83 Billion USD | 507.33% |
| 2016 | 302.9 Million USD | 509.46% |
| 2015 | 49.7 Million USD | -93.1% |
| 2014 | 720.1 Million USD | -5.37% |
| 2013 | 761 Million USD | 0.79% |
| 2012 | 755 Million USD | -0.76% |
| 2011 | 760.8 Million USD | 27.46% |
| 2010 | 596.9 Million USD | -16.8% |
| 2009 | 717.4 Million USD | -15.46% |
| 2008 | 848.6 Million USD | 9.75% |
| 2007 | 773.2 Million USD | -7.35% |
| 2006 | 834.5 Million USD | 13.92% |
| 2005 | 732.5 Million USD | 35.2% |
| 2004 | 541.8 Million USD | 56.45% |
| 2003 | 346.3 Million USD | 34.33% |
| 2002 | 257.8 Million USD | 72.1% |
| 2001 | 149.8 Million USD | -14.89% |
| 2000 | 176 Million USD | 17.33% |
| 1999 | 150 Million USD | 3.45% |
| 1998 | 145 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 242.8 Million USD | 40.84% |
| 2024 Q3 | 249.1 Million USD | 2.64% |
| 2024 Q1 | 172.4 Million USD | -58.87% |
| 2023 Q4 | 419.2 Million USD | 157.65% |
| 2023 Q2 | 209.6 Million USD | -9.85% |
| 2023 Q1 | 232.5 Million USD | 278.57% |
| 2023 Q3 | 162.7 Million USD | -22.38% |
| 2023 FY | 1.02 Billion USD | 342.52% |
| 2022 FY | 231.4 Million USD | -42.38% |
| 2022 Q2 | 153.7 Million USD | 109.97% |
| 2022 Q1 | 73.2 Million USD | 187.14% |
| 2022 Q3 | 194 Million USD | 26.22% |
| 2022 Q4 | -130.2 Million USD | -167.11% |
| 2021 Q2 | 141.9 Million USD | -28.37% |
| 2021 Q3 | 145.6 Million USD | 2.61% |
| 2021 Q1 | 198.1 Million USD | -40.64% |
| 2021 Q4 | -84 Million USD | -157.69% |
| 2021 FY | 401.6 Million USD | 392.29% |
| 2020 Q3 | 242.5 Million USD | 217.38% |
| 2020 Q1 | -508.5 Million USD | -258.56% |
| 2020 Q2 | -206.6 Million USD | 59.37% |
| 2020 Q4 | 333.7 Million USD | 37.61% |
| 2020 FY | -137.4 Million USD | -112.14% |
| 2019 FY | 1.13 Billion USD | 398.42% |
| 2019 Q1 | 246.1 Million USD | 127.31% |
| 2019 Q2 | 133.7 Million USD | -45.67% |
| 2019 Q3 | 431.1 Million USD | 222.44% |
| 2019 Q4 | 320.7 Million USD | -25.61% |
| 2018 Q4 | -901.1 Million USD | -655.55% |
| 2018 FY | -379.2 Million USD | -120.61% |
| 2018 Q1 | 174.7 Million USD | -86.1% |
| 2018 Q2 | 185 Million USD | 5.9% |
| 2018 Q3 | 162.2 Million USD | -12.32% |
| 2017 Q2 | 184.2 Million USD | -38.48% |
| 2017 FY | 1.83 Billion USD | 507.33% |
| 2017 Q4 | 1.25 Billion USD | 1172.47% |
| 2017 Q3 | 98.8 Million USD | -46.36% |
| 2017 Q1 | 299.4 Million USD | 349.55% |
| 2016 Q2 | -31.3 Million USD | -129.56% |
| 2016 Q3 | 158.8 Million USD | 607.35% |
| 2016 Q4 | 66.6 Million USD | -58.06% |
| 2016 FY | 302.9 Million USD | 509.46% |
| 2016 Q1 | 105.9 Million USD | -16.61% |
| 2015 Q4 | 127 Million USD | 472.07% |
| 2015 Q1 | 177.1 Million USD | 13.09% |
| 2015 Q3 | 22.2 Million USD | 114.05% |
| 2015 FY | 49.7 Million USD | -93.1% |
| 2015 Q2 | -158 Million USD | -189.22% |
| 2014 Q4 | 156.6 Million USD | -5.38% |
| 2014 FY | 720.1 Million USD | -5.37% |
| 2014 Q3 | 165.5 Million USD | -6.23% |
| 2014 Q2 | 176.5 Million USD | -20.32% |
| 2014 Q1 | 221.5 Million USD | -6.1% |
| 2013 Q2 | 152.1 Million USD | -30.42% |
| 2013 Q1 | 218.6 Million USD | 43.06% |
| 2013 Q4 | 235.9 Million USD | 52.78% |
| 2013 Q3 | 154.4 Million USD | 1.51% |
| 2013 FY | 761 Million USD | 0.79% |
| 2012 FY | 755 Million USD | -0.76% |
| 2012 Q3 | 178.1 Million USD | -16.97% |
| 2012 Q2 | 214.5 Million USD | 2.34% |
| 2012 Q1 | 209.6 Million USD | 33.84% |
| 2012 Q4 | 152.8 Million USD | -14.21% |
| 2011 Q1 | 208.9 Million USD | 498.57% |
| 2011 FY | 760.8 Million USD | 27.46% |
| 2011 Q4 | 156.6 Million USD | -18.22% |
| 2011 Q3 | 191.5 Million USD | -6.04% |
| 2011 Q2 | 203.8 Million USD | -2.44% |
| 2010 Q3 | 191.1 Million USD | 15.47% |
| 2010 Q1 | 205.4 Million USD | 32.35% |
| 2010 Q2 | 165.5 Million USD | -19.43% |
| 2010 FY | 596.9 Million USD | -16.8% |
| 2010 Q4 | 34.9 Million USD | -81.74% |
| 2009 Q1 | 202.2 Million USD | 20.72% |
| 2009 FY | 717.4 Million USD | -15.46% |
| 2009 Q4 | 155.2 Million USD | 3.54% |
| 2009 Q3 | 149.9 Million USD | -28.65% |
| 2009 Q2 | 210.1 Million USD | 3.91% |
| 2008 Q1 | 239.3 Million USD | -9.29% |
| 2008 Q2 | 227.1 Million USD | -5.1% |
| 2008 Q4 | 167.5 Million USD | -21.98% |
| 2008 Q3 | 214.7 Million USD | -5.46% |
| 2008 FY | 848.6 Million USD | 9.75% |
| 2007 Q2 | 231.5 Million USD | -0.81% |
| 2007 Q3 | 44.5 Million USD | -80.78% |
| 2007 FY | 773.2 Million USD | -7.35% |
| 2007 Q1 | 233.4 Million USD | -4.62% |
| 2007 Q4 | 263.8 Million USD | 492.81% |
| 2006 Q4 | 244.7 Million USD | 33.5% |
| 2006 FY | 834.5 Million USD | 13.92% |
| 2006 Q3 | 183.3 Million USD | -8.76% |
| 2006 Q1 | 205.6 Million USD | 3.01% |
| 2006 Q2 | 200.9 Million USD | -2.29% |
| 2005 FY | 732.5 Million USD | 35.2% |
| 2005 Q1 | 173.6 Million USD | -13.2% |
| 2005 Q2 | 190.7 Million USD | 9.85% |
| 2005 Q3 | 168.6 Million USD | -11.59% |
| 2005 Q4 | 199.6 Million USD | 18.39% |
| 2004 Q1 | 97.6 Million USD | 163.78% |
| 2004 Q3 | 127.9 Million USD | 9.97% |
| 2004 Q2 | 116.3 Million USD | 19.16% |
| 2004 FY | 541.8 Million USD | 56.45% |
| 2004 Q4 | 200 Million USD | 56.37% |
| 2003 Q2 | 89 Million USD | -34.22% |
| 2003 FY | 346.3 Million USD | 34.33% |
| 2003 Q3 | 85 Million USD | -4.49% |
| 2003 Q1 | 135.3 Million USD | 87.4% |
| 2003 Q4 | 37 Million USD | -56.47% |
| 2002 Q4 | 72.2 Million USD | 10.91% |
| 2002 FY | 257.8 Million USD | 72.1% |
| 2002 Q1 | 54.6 Million USD | 26.39% |
| 2002 Q2 | 65.9 Million USD | 20.7% |
| 2002 Q3 | 65.1 Million USD | -1.21% |
| 2001 Q3 | 27.4 Million USD | -36.57% |
| 2001 FY | 149.8 Million USD | -14.89% |
| 2001 Q2 | 43.2 Million USD | 20.0% |
| 2001 Q1 | 36 Million USD | -24.53% |
| 2001 Q4 | 43.2 Million USD | 57.66% |
| 2000 Q2 | 46.9 Million USD | 20.88% |
| 2000 Q1 | 38.8 Million USD | 0.0% |
| 2000 FY | 176 Million USD | 17.33% |
| 2000 Q4 | 47.7 Million USD | 11.97% |
| 2000 Q3 | 42.6 Million USD | -9.17% |
| 1999 FY | 150 Million USD | 3.45% |
| 1998 FY | 145 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 82.107% |
| Allurion Technologies Inc. | -82.3 Million USD | 1344.168% |
| Artivion, Inc. | -30.69 Million USD | 3436.592% |
| Avanos Medical, Inc. | -61.8 Million USD | 1756.958% |
| Butterfly Network, Inc. | -133.69 Million USD | 865.894% |
| Butterfly Network, Inc. | -133.69 Million USD | 865.894% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 260.672% |
| Boston Scientific Corporation | 1.59 Billion USD | 35.719% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | 7080.232% |
| CONMED Corporation | 64.45 Million USD | -1488.607% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 26.982% |
| Paragon 28, Inc. | -47.84 Million USD | 2240.423% |
| Glaukos Corporation | -134.66 Million USD | 860.428% |
| Globus Medical, Inc. | 122.87 Million USD | -733.381% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 4940.921% |
| Integer Holdings Corporation | 90.65 Million USD | -1029.619% |
| Medtronic plc | 3.67 Billion USD | 72.144% |
| Nevro Corp. | -92.21 Million USD | 1210.472% |
| Owlet, Inc. | -32.9 Million USD | 3212.367% |
| Penumbra, Inc. | 90.95 Million USD | -1025.844% |
| Vicarious Surgical Inc. | -71.07 Million USD | 1540.813% |
| Smith & Nephew plc | 263 Million USD | -289.354% |
| Sonendo, Inc. | -60.91 Million USD | 1780.921% |
| STERIS plc | 378.23 Million USD | -170.728% |
| Stryker Corporation | 3.16 Billion USD | 67.646% |
| Vapotherm, Inc. | -58.19 Million USD | 1859.662% |